Drug Type Chemical drugs |
Synonyms JNUTS 013, JNUTS013 |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22O6 |
InChIKeyPHPARPNDGGXMEO-VOTSOKGWSA-N |
CAS Registry2763983-45-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | United States | 14 Feb 2023 | |
Inflammation | Preclinical | China | 14 Feb 2023 |